Michael Narachi, CEO for Orexigen.

Michael Narachi, CEO for Orexigen. Photo by Jamie Scott Lytle.

— Diet pill maker Orexigen Therapeutics, one of San Diego’s struggling public companies, may soon auction itself off to the highest bidder in an attempt to fortify its finances...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129